Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

18 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Biltricide Articles

New public-private partnership to develop a treatment for schistosomiasis-infected pre-school children

2 July 2012

Germany's VFA and churches want more third-world aid

13 May 2009

The Lancet calls for health R&D G8

10 November 2008

UPDATE: Merck KGaA begins donation program in Madagascar

20 October 2008

World neglected tropical disease round-up

13 October 2008

Praziquantel may help slow HIV/AIDS transmission

28 July 2008

Merck KGaA/WHO start Africa schistosomiasis program

28 April 2008

US Pres promises $350M for neglected diseases

3 March 2008

US Pres promises $350M for neglected diseases

3 March 2008

Merck KGaA partners with WHO on schistosomiasis in Africa

30 April 2007

$8.9M neglected tropical disease research boost

19 March 2007

$8.9M neglected tropical disease research boost

19 March 2007

German drug firms pressured by WHO

30 October 2006

Showing 1-13 of 13 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Elan puts up formal "for sale" notice
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Elan puts up formal "for sale" notice
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS